Biohaven Ltd.BHVNNYSE
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank13
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P13
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-20.21%
2024113.21%
2023-14.60%
2022140.83%
202184.32%
2020-71.43%
20190.00%
20180.00%
20170.00%